Resistance-associated Mutations

Resistance-Associated Mutations is a genomic construct denoting specific viral genetic variants that confer reduced susceptibility to antiviral agents by altering drug-target interactions or viral replication fitness in the context of drug resistance evolution.

5K

Publications

311.7K

Citations

26.7K

Authors

4.7K

Institutions

Publications per year

2017–2026

1.2K

Authors

26.7K

  1. RW
    Robert W. Shafer

    Stanford University, United States

    78 publications · 8.1K citations

    47

    h-index

  2. MA
    Mark A. Wainberg

    Jewish General Hospital, Canada

    110 publications · 6.4K citations

    43

    h-index

  3. BL
    Brendan Larder

    Wellcome Trust, United Kingdom

    48 publications · 7K citations

    38

    h-index

  4. VC
    Vincent Cálvez

    Sorbonne Université, France

    105 publications · 4.8K citations

    36

    h-index

  5. DR
    Daniel R. Kuritzkes

    Harvard University, United States

    55 publications · 5.1K citations

    36

    h-index

1–5 of 26.7K

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 380 publications · 26.3K citations

    87

    h-index

  2. Journal of Virology

    JVI · 272 publications · 21.5K citations

    86

    h-index

  3. The Journal of Infectious Diseases

    JID · 210 publications · 17.5K citations

    77

    h-index

  4. AIDS

    260 publications · 16.4K citations

    71

    h-index

  5. Proceedings of the National Academy of Sciences

    PNAS · 62 publications · 9.4K citations

    54

    h-index

1–5